SEOM clinical guidelines for the treatment of early breast cancer
Clin. transl. oncol. (Print)
; 12(11): 711-718, nov. 2010. tab
Article
in English
| IBECS
| ID: ibc-124363
Responsible library:
ES1.1
Localization: BNCS
ABSTRACT
The incidence is increasing due to mammographic screening and an ageing population. In some countries the mortality rate has decreased especially in middleaged and younger groups because of improved treatment and possibly earlier detection. However, breast cancer is still the leading cause of cancer-related death in European women. The purpose of this work was to elaborate a Spanish Society of Medical Oncology guideline on pharmacologic interventions for early breast cancer (BC). We have compiled the latest advances in the management of this pathology either in the adjuvant and neoadjuvant setting, cytostatic and hormonal treatment, so that in a simple way could be useful to oncologist, residents and other related specialties (AU)
Search on Google
Collection:
National databases
/
Spain
Database:
IBECS
Main subject:
Societies, Medical
/
Breast Neoplasms
/
Clinical Trials as Topic
/
Medical Oncology
Type of study:
Practice guideline
/
Prognostic study
Limits:
Female
/
Humans
Country/Region as subject:
Europa
Language:
English
Journal:
Clin. transl. oncol. (Print)
Year:
2010
Document type:
Article
Institution/Affiliation country:
Complejo Hospitalario Universitario/Spain
/
Hospital Clinic i Provincial/Spain
/
Hospital Clínico Universitario Lozano Blesa/Spain
/
Hospital General Universitario de Elche/Spain
/
Hospital Universitario 12 de Octubre/Spain
/
Hospital del Mar/Spain
/
Instituto Catalán de Oncologia (ICO)/Spain